Importation and domestic transmission of Shigella sonnei resistant to ciprofloxacin — united states, may 2014–february 2015

Morbidity and Mortality Weekly Report

Volumn 64, Issue 12, 2015, Pages 318-320

  Bowen, Anna ^a   Hurd, Jacqueline ^a   Hoover, Cora ^b   Khachadourian, Yvette ^c   Traphagen, Elizabeth ^d   Harvey, Emily ^d   Libby, Tanya ^e   Ehlers, Sara ^b   Ongpin, Melissa ^b   Norton, J Corbin ^a   Bicknese, Amelia ^a   Kimura, Akiko ^f  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^c PHILADELPHIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^d MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

^e California Emerging Infections   (United States)

^f California Department of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN;

ADULT; ANTIBIOTIC RESISTANCE; CLUSTER ANALYSIS; DRUG EFFECTS; DYSENTERY, BACILLARY; EPIDEMIC; FEMALE; HUMAN; INTERNATIONAL COOPERATION; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PULSED FIELD GEL ELECTROPHORESIS; SHIGELLA SONNEI; STATISTICS AND NUMERICAL DATA; TRANSMISSION; TRAVEL; UNITED STATES; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; CLUSTER ANALYSIS; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; SHIGELLA SONNEI; TRAVEL; UNITED STATES; YOUNG ADULT;

EID: 84929940545     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States—major pathogens. Emerg Infect Dis 2011;17:7–15.
2. Christopher PR, David K V, John SM, Sankarapandian V. Antibiotic therapy for Shigella dysentery. Cochrane Database Syst Rev 2009;(4):CD006784.
3. Gu B, Cao Y, Pan S, et al. Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009. Int J Antimicrob Agents 2012;40:9–17.
4. CDC. National Antimicrobial Resistance Monitoring System: enteric bacteria human isolates final report 2012. Atlanta, GA: US Department of Health and Human Sevices, CDC; 2014. Available at http://www.cdc.gov/narms/pdf/2012-annual-report-narms-508c.pdf.
5. CDC. Health information for international travel 2014. New York, NY: Oxford University Press; 2014. Available at http://wwwnc.cdc.gov/travel/page/2014-yellow-book-about.
6. Kantele A, Lääveri T, Mero S, et al. Antimicrobials increase travelers’ risk of colonization by extended-spectrum beta-lactamase–producing Enterobacteriaceae. Clin Infect Dis 2015;60:837–46.
7. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Atlanta, GA: US Department of Health and Human Services. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf.